High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS

Table 5

Cox regression analysis at 12-month followup for patients without invasive catheterization (𝑛=58).

	Univariate		Multivariate
Condition	HR (95% CI)	𝑃	HR (95% CI)	𝑃
hsTnT > 0.013 ng/mL	11.45 (2.93–44.72)	<0.001	6.20 (1.31–29.27)	0.021
age > 65 years	1.21 (0.35–4.20)	0.760
Copeptin > 14 pmol/L	0.039 (0.00–95.09)	0.416
Severe symptoms	1.18 (0.27–4.74)	0.811
≥3 CVRF	3.67 (0.98–13.68)	0.053	1.39 (0.31–6.20)	0.667
Previous non-STEACS	17.53 (2.19–140.57)	0.007	12.00 (1.43–100.52)	0.022
ST deviation	2.78 (0.58–13.44)	0.202

≥3 CVRF: at least three cardiovascular risk factors. Previous non-STEACS: previous non-ST elevation acute coronary syndrome. HR: hazard ratio. CI: confidence interval.